Alkermes regulatory update

Alkermes Inc. (ALKS) ALKS (Cambridge, Mass.) received U.S. Patent No. 5,271,961 covering a method of producing OraLease microspheres. ALKS is developing OraLease to deliver via tablet or capsule drugs...